ARCHIVES

Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research

This article is from The Cancer Letter archive.

Vol. 08 No. 04 | January 22, 1982

Download PDF Visit The Full Archive

Related Articles

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

House Encourages NCI To continue Leadership Role As Coordinator Of Cancer Program

October 8, 1999

60-Mile Limit For Primate Facility Dropped

June 9, 1978

Nutrition Program Starts To Zero In On Mass Of Data, Plan Contract And Grant Project Areas

August 29, 1975

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001